FINDEX Inc.

Tokyo Stock Exchange 3649.T

FINDEX Inc. Operating Cash Flow for the year ending December 31, 2023: USD 5.97 M

FINDEX Inc. Operating Cash Flow is USD 5.97 M for the year ending December 31, 2023, a 12.92% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

FINDEX Inc. Operating Cash Flow for the year ending December 31, 2022 was USD 5.29 M, a -18.84% change year over year.
FINDEX Inc. Operating Cash Flow for the year ending December 31, 2021 was USD 6.52 M, a 24.14% change year over year.
FINDEX Inc. Operating Cash Flow for the year ending December 31, 2020 was USD 5.25 M, a -65.83% change year over year.
FINDEX Inc. Operating Cash Flow for the year ending December 31, 2019 was USD 15.36 M, a 181.88% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Tokyo Stock Exchange: 3649.T

FINDEX Inc.

CEO	Mr. Teruo Aibara
IPO Date	March 23, 2011
Location	Japan
Headquarters	Asahiseimei-Otemachi Building
Employees	290
Sector	Healthcare
Industries Medical Instruments 3D Printing Computers Hardware & Electronics Robotics Smartphones Software-as-a-Service (SaaS) Telehealth

Description

FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years